NCT07368985
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07368985
Title Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Prof. Dr. Remi A. Nout
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD

Facility Status City State Zip Country Details
Erasmus MC Rotterdam South Holland 3015 GD Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field